Sara Rodríguez Diego

Dr. Sara Rodríguez Diego

Complejo Hospitalario de Salamanca, Salamanca, Castille-Leon, Spain
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
FHFrancisco José Hidalgo
Francisco José Hidalgo
MAManuel Anguita
Manuel Anguita
JCJuan C. Castillo
Juan C. Castillo
SDSara Rodríguez Diego
Sara Rodríguez Diego
LPLaura Pardo
Laura Pardo
MRMartín Ruiz
Martín Ruiz

1 September 2016 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MPManuel Pan
Manuel Pan
SOSoledad Ojeda
Soledad Ojeda
EVElena Villanueva
Elena Villanueva
JCJorge Chavarria
Jorge Chavarria
MRMiguel Romero
Miguel Romero
JLJose Suarez De Lezo
Jose Suarez De Lezo

1 March 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
SOSoledad Ojeda
Soledad Ojeda
MPManuel Pan
Manuel Pan
AGAlejandro Gutierrez
Alejandro Gutierrez
MRMiguel Romero
Miguel Romero
JCJorge Chavarría
Jorge Chavarría
JLJose Suárez De Lezo
Jose Suárez De Lezo

3 October 2019 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
PDF file
JKJiwon Kim
Jiwon Kim
SKSpencer Krichevsky
Spencer Krichevsky
LXLola Xie
Lola Xie
MPMaria Chiara Palumbo
Maria Chiara Palumbo
SDSara Rodríguez Diego
Sara Rodríguez Diego
JWJonathan W. Weinsaft
Jonathan W. Weinsaft

1 April 2017 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
NMNeil K. Mehta
Neil K. Mehta
JKJiwon Kim
Jiwon Kim
JSJonathan Y. Siden
Jonathan Y. Siden
SDSara Rodríguez Diego
Sara Rodríguez Diego
JAJavid Alakbarli
Javid Alakbarli
JWJonathan W. Weinsaft
Jonathan W. Weinsaft
Mitral regurgitation (MR) is a common cause of morbidity worldwide and an accepted indication for interventional therapies which aim to reduce or resolve adverse clinical outcomes associated with MR. Cardiac magnetic resonance (CMR) provides highly accurate means of assessing MR, including a variety of approaches that can measure MR based on quantitative flow. Additionally, CMR is widely accepted as a reference standard for cardiac chamber quantification, enabling reliable detection of subtle changes in cardiac chamber size and function so as to guide decision-making regarding timing of mitral valve directed therapies. Beyond geometric imaging, CMR enables tissue characterization of ischemia and infarction in the left ventricular (LV) myocardium as well as within the mitral valve apparatus, thus enabling identification of structural substrates for MR. This review provides an overview of established and emerging CMR approaches to measure valvular regurgitation, including relative utility of different approaches for patients with primary or secondary MR. Clinical outcomes studies are discussed with focus on data demonstrating advantages of CMR for guiding diagnosis, risk stratification, and management of patients with known or suspected MR. Comparative data is reviewed with focus on diagnostic performance of CMR in comparison to conventional assessment via echocardiography (echo). Emerging literature is reviewed concerning potential new approaches that utilize CMR tissue characterization to guide clinical decision-making in order to improve therapeutic outcomes and clinical prognosis for patients with MR.

22 August 2017 in Echocardiography
Verified
Journal Article
Closed access
PDF file
JKJiwon Kim
Jiwon Kim
SDSara Rodríguez Diego
Sara Rodríguez Diego
ASAparna Srinivasan
Aparna Srinivasan
RBRachel‐Maria Brown
Rachel‐Maria Brown
MPMeridith P. Pollie
Meridith P. Pollie
JWJonathan W. Weinsaft
Jonathan W. Weinsaft